Skip to main content
The Canadian Journal of Cardiology logoLink to The Canadian Journal of Cardiology
. 2007 Mar 1;23(3):209–214. doi: 10.1016/s0828-282x(07)70746-8

Mitral regurgitation: Determinants of referral for cardiac surgery by Canadian cardiologists

Karine Toledano 1, Lawrence G Rudski 1, Thao Huynh 1, François Béïque 1, John Sampalis 1, Jean-François Morin 1,
PMCID: PMC2647869  PMID: 17347692

Abstract

PURPOSE:

Advances in surgery permit for earlier intervention with improved outcomes for patients with mitral regurgitation (MR). Many patients still appear to be referred to surgery late in their course. Consensus guidelines were compared with the surgical referral practices for MR among Canadian cardiologists.

METHODS:

A self-administered questionnaire was mailed to all adult cardiologists in Canada. This included seven case scenarios, as well as direct questions designed to establish the influence of factors including atrial fibrillation, pulmonary hypertension, left ventricular (LV) dilation, experience of the cardiac surgeon, symptoms and ejection fraction (EF) on referral.

RESULTS:

There were 319 respondents; LVEF was rated as extremely important in 71.5% of patients and moderately important in 26% of patients. In asymptomatic patients, EF of 50% to 60% was correctly identified as a trigger for surgery by 57.2 % of cardiologists, while only 15.6% of cardiologists correctly referred New York Heart Association class II patients with normal LV function. The group complied in only 4.77 of the seven case scenarios. Compliance was inversely related to years in practice for asymptomatic patients with mild LV dysfunction, as well as in overall compliance. Referral practices were similar among clinicians, echocardiographers, interventional cardiologists and researchers, with no differences in geographic region or academic affiliation.

CONCLUSION:

Compliance with published guidelines for patients with MR and either New York Heart Association class II or mild LV dysfunction among Canadian cardiologists was poor. Compliance was somewhat better in more recent graduates, suggesting the need to institute programs geared at enhancing knowledge of published standards and introduce practical tools to aid in their implementation.

Keywords: Echocardiography, Mitral valve, Regurgitation, Surgery


The optimal timing for surgery in mitral regurgitation (MR) has been an issue of debate over the past several decades. The medical community has moved from an era in which medical therapy was the only available option for MR to one in which surgical advances have superceded medical management. Despite studies supporting an early surgical approach to MR, many cardiovascular surgeons believe that patients are still referred late in the course of the disease.

The spectrum of mitral valve disease has changed significantly over the past 30 years, with a decline in rheumatic disease, and an increase in myxomatous degeneration and ischemic MR (1,2). As a result, more than two-thirds of patients are thought to be candidates for valve repair. Isolated MR is associated with elevated morbidity and mortality (3). The overall survival in chronic MR appears to improve with surgical therapy in patients with either normal or reduced left ventricular (LV) function (4).

The strongest and most consistent predictor of outcome, in terms of postoperative ejection fraction (EF) and survival after surgery, is preoperative EF (1,57). In fact, the best surgical outcome is observed in patients with EF of 60% or greater, with a low incidence of postoperative congestive heart failure and survival at 10 years, which is similar to that of an age-matched population (8). In addition, with the development of mitral valve repair and its lower associated operative mortality (911), the threshold for intervention in patients with MR should be lowered when repair is feasible. As a result, there has been a significant trend in the literature for surgical correction at an earlier stage, ideally when EF 60% or greater and before the end-systolic diameter exceeds 45 mm, to preserve ventricular function (1,8,1214).

As a result of the above findings, the American College of Cardiology (ACC), the American Heart Association (AHA), and more recently, the Canadian Cardiovascular Society, have published guidelines for the management of valvular heart disease, including indications for surgical intervention in patients with MR (15,16). Despite these guidelines, it was thought by many cardiovascular surgeons that patients were being referred late for surgery. The purpose of the present study was to evaluate whether Canadian cardiologists were following the ACC/AHA consensus criteria for surgical referral in mitral valve regurgitation, and to identify the instances in which these criteria were not being followed.

METHODS

All adult cardiologists and cardiac surgeons registered with the Royal College of Physicians and Surgeons of Canada were identified and were sent self-administered questionnaires. The questionnaire included seven case scenarios (Table 1) and direct questions designed to establish the influence of such factors as valve repairability based on echocardiographic appearance, new-onset atrial fibrillation (AF), concomitant ischemic heart disease, clinical symptoms such as dyspnea on exertion, and EF on surgical referral. The case scenarios assessed general adherence to ACC/AHA surgical guidelines for MR while emphasizing different surgical referral criteria.

TABLE 1.

Case scenario and surgical referral

Case Case description Referring cardiologists, % ACC/AHA recommendation
1 Asymptomatic, moderate MR, EF of 70% 1 No surgery, follow-up
2 Asymptomatic, moderate to severe MR, EF of 60%, repairable valve 6.4 Surgery, class IIa
3 Newly symptomatic, EF of 55%, valve not repairable 83.5 Surgery, class I
4 Symptomatic ischemic moderate to severe MR, EF of 60%, double-vessel disease 89.2 Surgery, class I
5 Asymptomatic, moderate to severe MR, EF of 60%, valve not repairable 9.6 Surgery, class IIa
6 Symptomatic NYHA class IV, EF of 30%, myxomatous valve 81.2 Surgery, class I
7 New-onset atrial fibrillation, moderate to severe MR, EF of 60% 35.2 Surgery, class IIa

Percentage of cardiologists referring patients for surgery for each scenario described, as well as the American College of Cardiology/American Heart Association (ACC/AHA) recommendation for the given scenario. EF Ejection fraction; MR Mitral regurgitation; NYHA New York Heart Association

A scoring system was devised to create an index of compliance with AHA/ACC guidelines, whereby the response to each case scenario was evaluated with respect to the recommendations of the ACC/AHA guidelines. This index of compliance also included the proportion of cardiologists who correctly identified the minimum decrease in LV function that would trigger surgical referral in asymptomatic and New York Heart Association (NYHA) class II patients with MR.

A total of two mailings were sent to increase the response rate. Confidentiality of the responding cardiologists was ensured.

Descriptive statistics, including frequency distributions for categorical variables and measures of central tendency and dispersion for continuous variables, were produced. The significance of factors associated with referral for surgery was evaluated for statistical significance with χ2 analysis. All associations with an alpha level below 5% were considered to be statistically significant.

RESULTS

Physician characteristics

Of the 776 eligible cardiologists, 319 (41%) responded to the questionnaire. The geographic distribution of the respondents differed significantly; however, it was proportional to the distribution of cardiologists in Canada. The majority of respondents resided in Ontario (36.2%) and Quebec (35.6%); 21% resided in the western provinces and 7% in the eastern provinces.

The largest group of respondents were between 36 and 45 years of age (41.4%), while only 4.1% of respondents were above the age of 65 years. Most respondents were male (87.8%), and graduated from medical school between 1970 and 1989 (72.7%). The mean (± SD) duration of practice was 14.4±9.6 years.

Most respondents were affiliated with university hospitals (66.1%), and the remainder were from community hospitals (33.8%). The majority of respondents incorporated clinical cardiology in their practice (92.8%). Of the respondents, 37.6% were involved in research, 31% were interventional cardiologists and 55.5% were trained in echocardiography.

Factors influencing referral for surgery

EF:

When asked about the importance of EF in determining the timing of surgery, 71.5% of cardiologists responded that it was of extreme importance, while 26% responded that it was of moderate importance. The minimum decrease in LV function to trigger surgical referral in patients with MR was assessed in asymptomatic and symptomatic NYHA class II patients. 57.2% of cardiologists would correctly refer asymptomatic patients for mitral valve repair or replacement based on an EF of 50% to 60%, 31.6% would wait for an EF of 49% or lower and 7.4% of cardiologists would refer patients with moderate to severe MR based on symptoms, regardless of EF (Table 2). There was no significant difference in the referral of asymptomatic patients on the basis of hospital versus community practice or field of expertise in cardiology (Tables 2 and 3). There were significant differences in referral patterns on the basis of the physician’s year of graduation, with more recently graduated physicians being more consistent with ACC/AHA guidelines in referring asymptomatic patients when the EF was in the 50% to 60% range (P=0.005) (Table 4).

TABLE 2.

University or community cardiology practice and surgical referral in patients with moderate to severe mitral regurgitation

Referral criteria evaluated Overall, n (%) Community, n (%) University, n (%) ACC/AHA guidelines
Asymptomatic (referral threshold)
  EF > 60% 2 (0.9) 1 (1.6) 1 (0.8) No surgery
  EF 50%–60% 123 (57.2) 37 (57.8) 64 (55.2) Surgery, class I
  EF 40%–49% 68 (31.6) 20 (31.2) 40 (34.5) Surgery, class I
  EF < 40% 6 (2.8) 3 (4.7) 3 (2.6) Surgery, class I
Symptoms regardless of EF 16 (7.4) 3 (4.7) 8 (6.9) Surgery, class I
NYHA II (referral threshold)
  EF > 60% 32 (15.5) 12 (20.0) 15 (13.6) Surgery, class I
  EF 50%–60% 11.5 (55.8) 33 (55.0) 64 (58.2) Surgery, class I
  EF 40%–49% 43 (20.9) 11 (18.3) 25 (22.7) Surgery, class I
  EF < 40% 3 (1.5) 1 (1.7) 1 (0.9) Surgery, class I
  Further symptoms 13 (6.3) 3 (5.0) 5 (4.5) Surgery, class I
New-onset AF 94 (32.9) 24 (30.8) 54 (34.4) Surgery, class IIa

In this survey, cardiologists identified the minimum decrease in left ventricular function that would trigger surgical referral for mitral valve surgery in both asymptomatic patients and symptomatic patients with New York Heart Association (NYHA) class II. The percentage of cardiologists who would refer asymptomatic patients with mild left ventricular dysfunction (ejection fraction [EF] of 60%), and new-onset atrial fibrillation (AF) was also surveyed. ACC/AHA American College of Cardiology/American Heart Association

TABLE 3.

Cardiology practice profile and surgical referral in patients with moderate to severe mitral regurgitation

Referral criteria evaluated Research, n (%) Clinical, n (%) Echo, n (%) Cath, n (%)
Asymptomatic (referral threshold)
  EF > 60% 1 (1.1) 2 (1.0) 0 (0) 1 (1.4)
  EF 50%–60% 58 (63) 112 (56.3) 81 (63.3) 41 (56.9)
  EF 40%–49% 28 (30.4) 65 (32.7) 36 (28.1) 23 (31.9)
  EF < 40% 1 (1.1) 6 (3.0) 2 (1.6) 3 (4.2)
Symptoms regardless of EF 4 (4.3) 14 (17) 9 (7) 4 (5.6)
NYHA II (referral threshold)
  EF > 60% 17 (19.5) 30 (15.6) 23 (18.8) 13 (18.3)
  EF 50%–60% 47 (54) 106 (55.2) 66 (54.1) 36 (50.7)
  EF 40–49% 18 (20.7) 40 (20.8) 23 (18.8) 17 (23.9)
  EF < 40% 0 (0) 3 (1.6) 2 (1.6) 2 (2.8)
  Further symptoms 5 (5.7) 13 (6.8) 8 (6.6) 3 (4.2)
New-onset AF 37 (35.2) 87 (32.9) 51 (31.9) 30 (33.0)

In this survey, cardiologists identified the minimum decrease in left ventricular function that would trigger surgical referral for mitral valve surgery in both asymptomatic patients and symptomatic patients with New York Heart Association (NYHA) class II. The percentage of cardiologists who would refer asymptomatic patients with mild left ventricular dysfunction (ejection fraction [EF] of 60%) and new-onset atrial fibrillation (AF) was also surveyed. Echo Cardiologists trained in echocardiography; Cath Interventional cardiologists

TABLE 4.

Year of graduation and surgical referral in patients with moderate to severe mitral regurgitation

Referral criteria evaluated 1969 and earlier, n (%) 1970–1979, n (%) 1980–1989, n (%)
Asymptomatic (referral threshold)
  EF > 60% 0 1 (1.3) 1 (1.1)
  EF 50%–60%* 13 (39.4) 36 (47.4) 61 (70.1)
  EF 40%–49% 12 (36.4) 32 (42.1) 19 (21.8)
  EF < 40% 1 (3) 4 (5.3) 0
Symptoms regardless of EF 7 (21.2) 3 (3.9) 6 (6.9)
  NYHA II (referral threshold)
  EF > 60% 4 (12.1) 10 (13.7) 14 (17.3)
  EF 50%–60% 16 (48.5) 37 (50.7) 52 (64.2)
  EF 40%–49% 9 (27.3) 18 (24.7) 12 (14.8)
  EF < 40% 0 3 (4.1) 0
  Further symptoms 4 (12.1) 5 (6.8) 3 (3.7)
New-onset AF** 19 (34.5) 32 (33.0) 33 (30.8)
*

P=0.0005;

**

P=0.032. In this survey, cardiologists identified the minimum decrease in left ventricular function that would trigger surgical referral for mitral valve surgery in both asymptomatic patients and symptomatic patients with New York Heart Association (NYHA) class II. The percentage of cardiologists who would refer asymptomatic patients with mild left ventricular dysfunction and new-onset atrial fibrillation (AF) was also surveyed. EF Ejection fraction

The minimum decrease in LV systolic function that would trigger surgical referral in NYHA class II patients was also assessed. Only 15.6% of cardiologists would correctly refer patients with NYHA class II and moderately severe MR to surgery if their LV function was normal (EF greater than 60%). 55.2% of cardiologists would wait until the EF dropped to 50% to 60%, while 20.8% would refer when the EF decreased further to 40% to 49%. Of the cardiologists surveyed, 63% would wait until the patient became more symptomatic to NYHA class III or IV (Tables 2 to 4). There was no difference in referral pattern based on year of graduation or practice profile.

AF:

New-onset AF with a dilated left atrium influenced 32.9% (P=0.004) of respondents to refer to surgery patients with moderate to severe MR and EF of 60%. There was no statistically significant difference in referral pattern based on community versus academic practice, research, angiography or echocardiography. Cardiologists who graduated earlier were more likely to refer patients with MR for surgery (34.5%) compared with cardiologists who graduated more recently (30.8%) (P=0.032) (Table 4).

Left atrial size was of little or no importance according to 44% of respondents. However, the presence of concomitant coronary artery disease (CAD), the degree of MR, pulmonary artery pressure and end-systolic diameter were of extreme or moderate importance in determining the timing for surgery according to 82.9% to 94% of cardiologists surveyed. The most important factor was the experience of the cardiac surgeon in valve repair at the given centre, and this was of extreme or moderate importance according to 97% of responding cardiologists (Table 5).

TABLE 5.

Parameters in the determination of timing of surgery

Left atrial size n (%) Degree of MR n (%) LVESD n (%) PA pressure n (%) Surgeon experience, n (%)
No importance 19 (6.1) 4 (1.3) 0 3 (1) 3 (1)
Little importance 118 (37.8) 18 (5.8) 19 (6.3) 32 (10.3) 14 (4.5)
Moderate importance 150 (48.1) 166 (53) 120 (30) 178 (57.2) 93 (30.8)
Extreme importance 25 (8) 124 (39.7) 163 (54) 98 (31.5) 200 (66.2)

LVESD Left ventricular end-systolic diameter; MR Mitral regurgitation; PA Pulmonary artery

Case scenarios

The surgical referral pattern was similar among clinical cardiologists, echocardiographers, researchers and interventional cardiologists (Tables 2 and 3). In asymptomatic patients with preserved LV function, 99% of cardiologists did not refer for surgery (ACC/AHA guidelines class IIb). However, cardiologists referred patients with MR to surgery late when they were asymptomatic with mild LV dysfunction (cases 2 and 5, Table 1), even if the valve was considered amenable to repair (case 2, Table 1).

Cardiologists were more consistent with practice guidelines in referring symptomatic patients with mild (83.5% of cardiologists) or severe (81.2% of cardiologists) LV dysfunction (cases 3 and 6, Table 1). The presence of concomitant CAD in symptomatic patients with mild LV dysfunction had the highest referral pattern, with 89.2% of cardiologists correctly referring these patients for surgery (case 4, Table 1). Symptomatic patients with mild LV dysfunction (EF of 60%) and new-onset AF were also referred late for surgery (case 7, Table 1).

The adherence to ACC/AHA guidelines was evaluated on the basis of the seven clinical scenarios in Table 1 and the minimum decrease in LV function that would trigger surgical referral in asymptomatic and NYHA II patients. The mean score was 4.77 of seven (Table 6). There was a slightly lower level of compliance with ACC/AHA guidelines among cardiologists who graduated earlier (P<0.05).

TABLE 6.

Overall adherence to American College of Cardiology/American Heart Association guidelines

Mean score (of 7), %
Overall 4.77
Year graduated medical school*
  1969 and earlier 4.2
  1970–1979 4.4
  1980–1989 4.8
  1990 and later 4.8
Angiography
  Yes 4.8
  No 4.7
Echocardiography
  Yes 4.8
  No 4.6
Research
  Yes 4.9
  No 4.6
Practice type
  Community 4.8
  University 4.8
Clinical cardiology
  Yes 4.8
  No 4.7
*

P<0.05

DISCUSSION

Our study supports the hypothesis that patients with MR are being referred later than recommended by the ACC/AHA guidelines for surgical management of mitral valve disease. There was surprising under-referral for asymptomatic and symptomatic patients with EF between 50% to 60%, despite consistent literature illustrating the survival benefits of surgical referral for valve repair before the onset of irreversible LV dysfunction. In their study, Enriquez-Sarano et al (5) clearly demonstrated that 10-year survival in patients with isolated MR who were undergoing valve repair was dependent on preoperative EF. Survival in patients undergoing valve repair with preoperative EF of 60% or greater did not differ from that of the age-matched population. In addition, they showed a similar stepwise decline in survival curves in relation to EF in patients undergoing mitral valve replacement. These data are not surprising, in view of our current understanding of the natural history of MR; the onset of contractile dysfunction typically occurs while patients are asymptomatic, and ejection phase indexes of LV performance remain within the normal range (17,18) as a result of the favourable preoperative loading conditions (1921). By the time patients become overtly symptomatic with exhaustion, decreased exercise tolerance and congestive heart failure, severe irreversible contractile dysfunction may have already developed (22,23). Thus, surgery is recommended for MR, even when symptoms are absent or mild (NYHA class I or II) and LV function is near the lower limit of normal (LV function 55% to 60% or fractional shortening 30% to 32%) (24,25). The ACC/AHA guidelines for MR support surgery for symptomatic or asymptomatic patients with mild LV dysfunction, defined as EF of 50% to 60% and end-systolic dimension of 45 mm to 50 mm. They also recommend mitral valve surgery in patients experiencing dyspnea (NYHA functional class II, III or IV) even if they have normal ventricular function, defined as EF of greater than 60% and end-systolic dimension of less than 45 mm (15).

Despite the evidence for earlier surgical referral in MR, our study suggests that cardiologists delay referral in asymptomatic patients with mild LV dysfunction. Only 57% of cardiologists surveyed correctly identified an EF of 50% to 60% in asymptomatic patients as the minimum decrease in LV function that should trigger surgical referral in patients with MR. Among these patients, cardiologists who graduated more recently answered more consistently in accordance with ACC/AHA guidelines, but the surgical referral pattern was similar among clinical cardiologists, echocardiographers, researchers and angiographers (Tables 2 to 4). An increase in LV size was considered to be of moderate or extreme importance by 84% of cardiologists in determining the timing of surgery, while mild LV dysfunction was not recognized as an important indicator of referral. LV dilation may be considered by the cardiologists surveyed as a more ominous sign of LV dysfunction than an EF of 60%. The low surgical referral in patients with significant MR and EF of 60% may also represent a failure to appreciate that EF of 60% in this setting represents mild LV dysfunction.

Cardiologists were more consistent with practice guidelines in referring symptomatic patients with mild or severe LV dysfunction (cases 3 and 6). The presence of concomitant CAD in symptomatic patients with mild LV dysfunction had the highest referral pattern with 89.2% of cardiologists correctly referring these patients for surgery (case 4).

In the ACC/AHA guidelines for the management of patients with valvular heart disease, the feasibility of repair is an important criterion in the decision to refer patients for surgery. In the case scenarios, there was poor referral of asymptomatic patients with mild LV dysfunction and a nonrepairable valve (case 5), although this is considered a class IIa indication. The referral was not increased when this case scenario was modified to include a repairable valve (case 2). Although the presence of a repairable valve in these two case scenarios did not seem to impact referral, most cardiologists mentioned that experience of the cardiac surgeon in valve repair was of moderate or extreme importance.

In asymptomatic patients with mild LV dysfunction (EF of 60%) and new-onset AF, the surgical referral was only 35.2% (class IIa indication). There was also significant under-referral for valve repair in patients with new-onset AF. Studies have shown that preoperative duration of AF of less than three months is prognostic for conversion to sinus rhythm postoperatively (26), with a dramatic decrease in the conversion rate once the AF is present for over a year (27). According to these studies, the development of AF may be considered a turning point in the course of MR and may serve as an impetus for surgical referral even in asymptomatic patients with a preserved LV function (class IIa indication).

Late surgical referral may also be due to the difficulty in referring patients who have few, if any, symptoms to surgery, which certainly carries its risks. Cardiologists may also not yet be confident of the success of valve repair in their particular institution, and may also be biased by the morbidity and mortality rates before the surgical techniques were perfected. In fact, 97% of cardiologists indicated that the experience of the cardiac surgeon in valve repairs was of extreme or moderate importance in their decision to refer the patient to cardiac surgery.

Guidelines applied in practice

There has been a recent interest in literature on adherence to guidelines. Studies have looked at adherence to guidelines in hypertension management (28), diabetes (29), community-acquired pneumonias (30) and acute coronary syndromes (31), among others. These studies consistently show a lack of adherence to guidelines (in the 55% to 85% range), with consequent increase in morbidity and mortality for patients in whom the guidelines were not followed.

Although practice guidelines have been shown to influence practice patterns, the degree of improvement varies considerably (32). The dissemination of information within the guidelines has proven to be an important determinant of their adherence. There has been evidence for the use of ‘opinion leaders’ –trusted individuals or department heads in institutions to propagate evidence-based guidelines to their colleagues. In addition, the use of critical pathways has been established to improve adherence to guidelines and may have led to better outcomes for cardiac surgery (33), chest pain (34) and thrombolysis (35).

The lack of adherence to evidence-based guidelines in myocardial infarctions (31), including the underuse of acetylsalicylic acid, heparin, beta-blockers and reperfusion therapy, has led to several initiatives to improve the application of evidence-based medicine in this setting. The Guidelines Applied in Practice Initiative (36) is a quality-of-care project devised to implement evidence-based guidelines for acute coronary syndromes using tools such as critical pathways, assignment of local physician and nurse opinion leaders, grand rounds site visits, standard orders, pocket cards, chart stickers and patient handouts (36). This intervention resulted in a significant increase in adherence to key treatments in the acute myocardial infarct setting. Similar initiatives may be necessary to improve adherence to guidelines in the management of valvular heart disease.

Duration of practice since graduation

Cardiologists who completed their training more recently were likely to be more consistent with current guidelines. In the present survey, 70% of the more recent graduates referred patients for surgery with mildly reduced LV systolic function, compared with only 39% of those who completed their training earlier. Similarly, they had a significantly higher compliance scores in the seven case scenarios, scoring 4.8 versus 4.2 of seven cases. This is consistent with previous findings investigating the relationship between clinical experience and quality of health care. Norcini et al (37) reported a 0.5% increase in mortality per year since medical school graduation in a group of 4546 cardiologists, internists and family physicians caring for acute myocardial infarction patients. In a comprehensive review of all such studies, Choudhry et al (38) found that 70% demonstrated a consistently or partially negative association between time in practice or physician age and adherence to standards of care. This negative association was similar in either self-reported studies or those using objective measures. There are many explanations for this, including older physicians being less likely to adopt newly proven strategies into their practices or being less familiar with newer technologies. In addition, older physicians may rely more on humanistic rather than technical aspects of medicine, and may draw on experience in similar cases. Finally, while recognizing that guidelines of practice are usually written based on expert consensus, they often have varying levels of strength of evidence, and older physicians may draw on their experience in similar cases. Unlike the management of acute myocardial infarction or unstable angina, in the case of surgical management of MR, the level of evidence is much weaker. There are no randomized trials, and most data come from retrospective observational studies, often from ultraspecialized single centres. In the setting of ischemic MR, studies have demonstrated that its mere presence markedly increases long-term mortality, but we lack studies proving that its repair will result in an improved outcome. Despite this, current Canadian guidelines suggest mitral repair or replacement for 2+ or 3+ MR, or greater. Cardiologists who completed their training more recently had studied these guidelines, particularly for the purpose of passing examinations, but may not appreciate the above limitations of such guidelines when faced with an individual patient.

Limitations

The present study has some limitations. The sample of cardiologists who agreed to participate in the study may differ in their attitudes and beliefs from the general population of cardiologists practising in Canada. However, it is likely that the cardiologists who participated in the survey have a greater interest in the management of valvular heart disease. As such, our findings may represent a more positive scenario than in the broader cardiology practice. The present study was performed on Canadian cardiologists before the publication of Canadian guidelines for surgical management of valvular heart disease. However, this is unlikely to be a significant factor in the lack of adherence to the guidelines because the American guidelines are widely accepted in Canada. Finally, the present study used surveys with clinical scenarios from which we attempted to deduce clinical practice. Although it is possible that the responses to the scenarios differed from clinical practice, we would have expected that this may lead to a bias in favour of the guidelines.

CONCLUSION

The present survey of Canadian cardiologists suggests that there is an overall 66% compliance with ACC/AHA guidelines for surgical referral in patients with MR, but our data suggest that there is variation in practice among Canadian cardiologists. Cardiologists who trained more recently tended to adhere more closely to the ACC/AHA guidelines. There is late surgical referral compared with ACC/AHA guidelines in asymptomatic patients with new-onset AF and mildly depressed LV function (EF 50% to 60%), even if the valve is considered repairable. There is also late referral in symptomatic patients with NYHA class II and preserved LV function (EF greater than 60%). However, surgical referral is consistent with ACC/AHA guidelines in symptomatic patients with either mild or severe LV dysfunction. It is crucial to identify and refer patients with MR who are amenable to valve repair early – assuming a low risk of the procedure in the given centre – to avoid the need for prosthetic devices, decreased postoperative EF and excess perioperative and long-term mortality. The management of valvular heart disease, including that of MR, should be guided by the use of office- and hospital-based critical pathways and dissemination of guidelines through local ‘opinion leaders’. This will result in improved adherence to the guidelines for valvular heart disease in a manner similar to that seen with the treatment of CAD. This will ultimately lead to improved surgical referral in the identified scenarios.

Acknowledgments

Special thanks to Edwards LifeSciences for their financial support.

REFERENCES

  • 1.Cooper HA, Gersh BJ. Treatment of chronic mitral regurgitation. Am Heart J. 1998;135:925–36. doi: 10.1016/s0002-8703(98)70056-0. [DOI] [PubMed] [Google Scholar]
  • 2.Waller BF, Morrow AG, Maron BJ, et al. Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: Analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J. 1982;104:276–88. doi: 10.1016/0002-8703(82)90204-6. [DOI] [PubMed] [Google Scholar]
  • 3.Rapaport E. Natural history of aortic and mitral valve disease. Am J Cardiol. 1975;35:221–7. doi: 10.1016/0002-9149(75)90005-3. [DOI] [PubMed] [Google Scholar]
  • 4.Delahaye JP, Gare JP, Viguier E, Delahaye F, De Gevigney G, Milon H. Natural history of severe mitral regurgitation. Eur Heart J. 1991;35(12(Suppl B)):5–9. doi: 10.1093/eurheartj/12.suppl_b.5. [DOI] [PubMed] [Google Scholar]
  • 5.Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994;90:830–7. doi: 10.1161/01.cir.90.2.830. [DOI] [PubMed] [Google Scholar]
  • 6.Quinones MA. Management of mitral regurgitation. Optimal timing for surgery. Cardiol Clin. 1998;16:421–35. doi: 10.1016/s0733-8651(05)70023-0. [DOI] [PubMed] [Google Scholar]
  • 7.Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, Frye RL. Congestive heart failure after surgical correction of mitral regurgitation. A long-term study. Circulation. 1995;92:2496–503. doi: 10.1161/01.cir.92.9.2496. [DOI] [PubMed] [Google Scholar]
  • 8.Enriquez-Sarano M, Orszulak TA, Schaff HV, Abel MD, Tajik AJ, Frye RL. Mitral regurgitation: A new clinical perspective. Mayo Clin Proc. 1997;72:1034–43. doi: 10.4065/72.11.1034. [DOI] [PubMed] [Google Scholar]
  • 9.Duran CG, Pomar JL, Revuelta JM, et al. Conservative operation for mitral insufficiency: Critical analysis supported by postoperative hemodynamic studies of 72 patients. J Thorac Cardiovasc Surg. 1980;79:326–37. [PubMed] [Google Scholar]
  • 10.Perier P, Deloche A, Chauvaud S, et al. Comparative evaluation of mitral valve repair and replacement with Starr, Bjork, and porcine valve prostheses. Circulation. 1984;70:I187–92. [PubMed] [Google Scholar]
  • 11.Yacoub M, Halim M, Radley-Smith R, McKay R, Nijveld A, Towers M. Surgical treatment of mitral regurgitation caused by floppy valves: Repair versus replacement. Circulation. 1981;64:II210–6. [PubMed] [Google Scholar]
  • 12.Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: Results and clinical implications. J Am Coll Cardiol. 1994;24:1536–43. doi: 10.1016/0735-1097(94)90151-1. [DOI] [PubMed] [Google Scholar]
  • 13.Stewart WJ. Choosing the “golden moment” for mitral valve repair. J Am Coll Cardiol. 1994;24:1544–6. doi: 10.1016/0735-1097(94)90152-x. [DOI] [PubMed] [Google Scholar]
  • 14.Sousa Uva M, Dreyfus G, Rescigno G, et al. Surgical treatment of asymptomatic and mildly symptomatic mitral regurgitation. J Thorac Cardiovasc Surg. 1996;112:1240–9. doi: 10.1016/s0022-5223(96)70137-x. [DOI] [PubMed] [Google Scholar]
  • 15.Bonow RO, Carabello B, de Leon AC, Jr, et al. ACC/AHA Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease) Circulation. 1998;98:1949–84. doi: 10.1161/01.cir.98.18.1949. [DOI] [PubMed] [Google Scholar]
  • 16.Jamieson WE, Cartier PC, Allard M, et al. Surgical management of valvular heart disease 2004. Can J Cardiol. 2004;20(Suppl E):7E–120E. [PubMed] [Google Scholar]
  • 17.Starling MR, Kirsh MM, Montgomery DG, Gross MD. Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol. 1993;22:239–50. doi: 10.1016/0735-1097(93)90840-w. [DOI] [PubMed] [Google Scholar]
  • 18.Wisenbaugh T. Does normal pump function belie muscle dysfunction in patients with chronic severe mitral regurgitation? Circulation. 1988;77:515–25. doi: 10.1161/01.cir.77.3.515. [DOI] [PubMed] [Google Scholar]
  • 19.Starling M. Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation. Circulation. 1995;92:811–8. doi: 10.1161/01.cir.92.4.811. [DOI] [PubMed] [Google Scholar]
  • 20.Borow KM, Green LH, Mann T, et al. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med. 1980;68:655–63. doi: 10.1016/0002-9343(80)90251-x. [DOI] [PubMed] [Google Scholar]
  • 21.Mirsky I, Corin WJ, Murakami T, Grimm J, Hess OM, Krayenbuehl HP. Correction for preload in assessment of myocardial contractility in aortic and mitral valve disease. Application of the concept of systolic myocardial stiffness. Circulation. 1988;78:68–80. doi: 10.1161/01.cir.78.1.68. [DOI] [PubMed] [Google Scholar]
  • 22.Ross J., Jr Left ventricular function and the timing of surgical treatment in valvular heart disease. Ann Intern Med. 1981;94:498–504. doi: 10.7326/0003-4819-94-4-498. [DOI] [PubMed] [Google Scholar]
  • 23.Braunwald E. Mitral regurgitation: Physiologic, clinical and surgical considerations. N Engl J Med. 1969;281:425–33. doi: 10.1056/NEJM196908212810807. [DOI] [PubMed] [Google Scholar]
  • 24.Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996;335:1417–23. doi: 10.1056/NEJM199611073351902. [DOI] [PubMed] [Google Scholar]
  • 25.Ross J., Jr The timing of surgery for severe mitral regurgitation. N Engl J Med. 1996;335:1456–8. doi: 10.1056/NEJM199611073351909. [DOI] [PubMed] [Google Scholar]
  • 26.Chua YL, Schaff HV, Orszulak TA, Morris JJ. Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty? J Thorac Cardiovasc Surg. 1994;107:408–15. [PubMed] [Google Scholar]
  • 27.Obadia JF, el Farra M, Bastien OH, Lievre M, Martelloni Y, Chassignolle JF. Outcome of atrial fibrillation after mitral valve repair. J Thorac Cardiovasc Surg. 1997;114:179–85. doi: 10.1016/S0022-5223(97)70142-9. [DOI] [PubMed] [Google Scholar]
  • 28.Khan N, Chockalingam A, Campbell NR. Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol. 2002;18:657–61. [PubMed] [Google Scholar]
  • 29.Koll E, Hewitt JB. Adherence to 1997 diabetes screening guidelines in a large ambulatory clinic. Diabetes Educ. 2001;27:387–92. doi: 10.1177/014572170102700308. [DOI] [PubMed] [Google Scholar]
  • 30.Malone DC, Shaban HM. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia. Ann Pharmacother. 2001;35:1180–5. doi: 10.1345/aph.10283. [DOI] [PubMed] [Google Scholar]
  • 31.Cannon C, Bahit MC, Haugland JM, et al. Underutilization of Evidence-Based Medications in Acute ST Elevation Myocardial Infarction: Results of the Thrombolysis In Myocardial Infarction (TIMI) 9 Registry. Crit Path Cardiol. 2002;1:44–52. doi: 10.1097/00132577-200203000-00007. [DOI] [PubMed] [Google Scholar]
  • 32.Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations. Lancet. 1993;342:1317–22. doi: 10.1016/0140-6736(93)92244-n. [DOI] [PubMed] [Google Scholar]
  • 33.Velasco FT, Ko W, Rosengart T, et al. Cost containment in cardiac surgery: Results with a critical pathway for coronary bypass surgery at the New York Hospital-Cornell Medical Center. Best Pract Benchmarking Healthc. 1996;1:21–8. [PubMed] [Google Scholar]
  • 34.Nichol G, Walls R, Goldman L, et al. A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: Recommendations and potential impact. Ann Intern Med. 1997;127:996–1005. doi: 10.7326/0003-4819-127-11-199712010-00009. [DOI] [PubMed] [Google Scholar]
  • 35.Cannon CP, Johnson EB, Cermignani M, Scirica BM, Sagarin MJ, Walls RM. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction. Clin Cardiol. 1999;22:17–20. doi: 10.1002/clc.4960220108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mehta RH, Montoye CK, Gallogly M, et al. GAP Steering Committee of the American College of Cardiology Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287:1269–76. doi: 10.1001/jama.287.10.1269. [DOI] [PubMed] [Google Scholar]
  • 37.Norcini JJ, Lipner RS, Benson JA, Jr, Webster GD. An analysis of the knowledge base of practicing internists as measured by the 1980 recertification examination. Ann Intern Med. 1985;102:385–9. doi: 10.7326/0003-4819-102-3-385. [DOI] [PubMed] [Google Scholar]
  • 38.Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: The relationship between clinical experience and quality of health care. Ann Int Med. 2005;142:260–73. doi: 10.7326/0003-4819-142-4-200502150-00008. [DOI] [PubMed] [Google Scholar]

Articles from The Canadian Journal of Cardiology are provided here courtesy of Pulsus Group

RESOURCES